Correlation Between Inhibikase Therapeutics and Genelux Common
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Genelux Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Genelux Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Genelux Common, you can compare the effects of market volatilities on Inhibikase Therapeutics and Genelux Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Genelux Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Genelux Common.
Diversification Opportunities for Inhibikase Therapeutics and Genelux Common
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibikase and Genelux is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Genelux Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genelux Common and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Genelux Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genelux Common has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Genelux Common go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Genelux Common
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.08 times more return on investment than Genelux Common. However, Inhibikase Therapeutics is 1.08 times more volatile than Genelux Common. It trades about 0.05 of its potential returns per unit of risk. Genelux Common is currently generating about -0.06 per unit of risk. If you would invest 228.00 in Inhibikase Therapeutics on September 12, 2024 and sell it today you would earn a total of 92.00 from holding Inhibikase Therapeutics or generate 40.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Genelux Common
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Genelux Common |
Inhibikase Therapeutics and Genelux Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Genelux Common
The main advantage of trading using opposite Inhibikase Therapeutics and Genelux Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Genelux Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genelux Common will offset losses from the drop in Genelux Common's long position.| Inhibikase Therapeutics vs. Equillium | Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Valneva SE ADR | Inhibikase Therapeutics vs. Vivani Medical |
| Genelux Common vs. Equillium | Genelux Common vs. DiaMedica Therapeutics | Genelux Common vs. Valneva SE ADR | Genelux Common vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |